Palbocent 125mg

Palbocent is a targeted therapy known as a CDK 4/6 inhibitor.

It is not a traditional chemotherapy.

Taken in combination with certain hormonal therapies, Palbocent works to put the brakes on cell growth in both healthy and cancer cells.

This helps slow the progression of cancer, but it can also cause side effects, some of which are serious.

Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.